Key Insights

Highlights

Success Rate

96% trial completion (above average)

Published Results

45 trials with published results (21%)

Research Maturity

145 completed trials (68% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

2.8%

6 terminated out of 212 trials

Success Rate

96.0%

+9.4% vs benchmark

Late-Stage Pipeline

34%

72 trials in Phase 3/4

Results Transparency

31%

45 of 145 completed with results

Key Signals

45 with results96% success

Data Visualizations

Phase Distribution

148Total
Not Applicable (62)
P 1 (1)
P 2 (13)
P 3 (14)
P 4 (58)

Trial Status

Completed145
Unknown22
Recruiting17
Not Yet Recruiting11
Withdrawn6
Terminated6

Trial Success Rate

96.0%

Benchmark: 86.6%

Based on 145 completed trials

Clinical Trials (212)

Showing 20 of 20 trials
NCT07746726Phase 3RecruitingPrimary

Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus Maintenance in Adults

NCT07828977Phase 4Not Yet Recruiting

Effect of Neuromuscular Blockade on Video Laryngeal Mask Airway Ventilation

NCT06409260Not ApplicableCompletedPrimary

Neuromuscular Monitoring in Children (6 Months - 2 Years) With Electromyography and Acceleromyography

NCT06681662Phase 4CompletedPrimary

Ephedrine for Reducing Onset Time of Rocurinium in Elderly Patients

NCT07435792Not ApplicableEnrolling By Invitation

TetraGraph to Evaluate Onset and Recovery Times of Rocuronium

NCT07446309Phase 2CompletedPrimary

Safety and Efficacy of HRS-9190 Compared to Cisatracurium for Continuous Intravenous Infusion in Adults

NCT06740877CompletedPrimary

Skeletal Muscle Index and a Neuromuscular Blocking Agent

NCT07759206Not ApplicableCompletedPrimary

Gentle Skin Abrasion and EMG-Based Neuromuscular Blockade Monitoring

NCT07739862Not Yet RecruitingPrimary

Acceleromyography Versus Electromyography for Neuromuscular Recovery Assessment at the End of Surgery

NCT06220136CompletedPrimary

Comparison of the Performances of the cTOFR and the mTOFR During Reversal of Deep Neuromuscular Blockade With Sugammadex

NCT07580144Completed

Effect of Sarcopenia and Frailty on Rocuronium Pharmacodynamics in Geriatric Patients

NCT07706504Not ApplicableRecruitingPrimary

Comparison of Two Quantitative EMG Monitors for Deep Neuromuscular Block in Laparoscopic/Robotic and VATS Surgery

NCT05006807CompletedPrimary

Comparison Neuromuscular Blockade Monitors

NCT07627750Not ApplicableNot Yet Recruiting

Low-Dose Rocuronium Maintenance During Spine Surgery With Intraoperative Neurophysiological Monitoring

NCT05993390Not ApplicableRecruitingPrimary

Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients

NCT07404579Phase 2CompletedPrimary

Safety and Efficacy of HRS-9190 Compared to Rocuronium for Bolus Maintenance in Adults

NCT04911088CompletedPrimary

Electromyographic Calibration Guided by Depth of Anesthesia

NCT05471882Active Not Recruiting

Predicting Neuromuscular Recovery in Surgical Patients Using Machine Learning

NCT06945341Suspended

International Focus Group Discussion on Neuromuscular Monitoring.

NCT07003061Completed

Sarcopenia and Neuromuscular Block in Gastrointestinal Cancer Surgery

Scroll to load more

Research Network

Activity Timeline